Oncology Grand Rounds Series: Part 2 — Hodgkin and Non-Hodgkin Lymphomas

1:56:01
 
Share
 

Manage episode 236839109 series 1464173
By Discovered by Player FM and our community — copyright is owned by the publisher, not Player FM, and audio streamed directly from their servers.

Video proceedings from the second in a series of 6 integrated symposia held at the 2019 ONS Annual Congress. Featuring perspectives from Dr Christopher R Flowers, Ms Amy Goodrich, Dr Patrick B Johnston and Ms Robin Klebig:

  • Introduction (00:00)
    • Program overview: Dr Love
  • Hodgkin Lymphoma (HL) (2:51)
  • Case (Ms Klebig): A woman in her early 50s with HL who received up-front brentuximab vedotin with ABVD on a clinical trial and nivolumab after relapse (5:57)
  • Case (Ms Goodrich): A man in his mid-50s with relapsed HL who received brentuximab vedotin as a bridge to allogenic transplant (26:12)
  • Follicular Lymphoma (FL) (37:16)
  • Case (Ms Klebig): A man in his late 50s with multiply relapsed FL who received lenalidomide/rituximab with response and clinical improvement (38:46)
  • Case (Ms Goodrich): A man in his late 40s with relapsed FL who received copanlisib (1:07:01)
  • Mantle Cell Lymphoma (MCL) (1:09:53)
  • Case (Ms Goodrich): A man in his early 80s with relapsed MCL and multiple comorbidities who received acalabrutinib (1:19:36)
  • Case (Ms Goodrich): A man in his early 60s who received multiple lines of therapy for relapsed MCL, including venetoclax/rituximab (1:27:21)
  • Diffuse Large B-Cell Lymphoma (DLBCL) (1:34:06)
  • Case (MS Klebig): A woman in her mid-30s with relapsed triple-hit DLBCL who underwent chimeric antigen receptor T-cell therapy (1:34:12)
  • Case (Ms Klebig): A woman in her mid-30s with DLBCL who received CNS prophylaxis with high-dose methotrexate (1:37:16)

Select publications

2175 episodes available. A new episode about every 2 days averaging 75 mins duration .